| Year |
Citation |
Score |
| 2021 |
Yamada S, Bartunek J, Behfar A, Terzic A. Mass Customized Outlook for Regenerative Heart Failure Care. International Journal of Molecular Sciences. 22. PMID 34768825 DOI: 10.3390/ijms222111394 |
0.342 |
|
| 2021 |
Arrell DK, Crespo-Diaz RJ, Yamada S, Jeon R, Garmany A, Park S, Adolf JP, Livia C, Hillestad ML, Bartunek J, Behfar A, Terzic A. Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome. Stem Cells Translational Medicine. PMID 34047493 DOI: 10.1002/sctm.20-0509 |
0.767 |
|
| 2020 |
Li M, Yamada S, Shi A, Singh RD, Rolland TJ, Jeon R, Lopez N, Shelerud L, Terzic A, Behfar A. Brachyury engineers cardiac repair competent stem cells. Stem Cells Translational Medicine. PMID 33098750 DOI: 10.1002/sctm.20-0193 |
0.36 |
|
| 2020 |
Bansal A, Pandey MK, Yamada S, Goyal R, Schmit NR, Jeon R, Nesbitt JJ, Witt TA, Singh RD, Gunderson TM, Boroumand S, Li M, Crespo-Diaz RJ, Hillestad ML, Terzic A, et al. [Zr]Zr-DBN labeled cardiopoietic stem cells proficient for heart failure. Nuclear Medicine and Biology. 90: 23-30. PMID 32957056 DOI: 10.1016/J.Nucmedbio.2020.09.001 |
0.773 |
|
| 2020 |
Klepinin A, Zhang S, Klepinina L, Rebane-Klemm E, Terzic A, Kaambre T, Dzeja P. Adenylate Kinase and Metabolic Signaling in Cancer Cells. Frontiers in Oncology. 10: 660. PMID 32509571 DOI: 10.3389/Fonc.2020.00660 |
0.324 |
|
| 2020 |
Arrell DK, Rosenow CS, Yamada S, Behfar A, Terzic A. Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome. Npj Regenerative Medicine. 5: 5. PMID 32194990 DOI: 10.1038/S41536-020-0091-6 |
0.471 |
|
| 2020 |
Arocha SRR, Li M, Singh RD, Terzic A, Behfar A. Nucleic‐Acid Mediated Expression of Cardiopoietic Markers in Human Umbilical Cord‐Derived Mesenchymal Stem Cells The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.02946 |
0.379 |
|
| 2019 |
Yamada S, Arrell DK, Rosenow CS, Bartunek J, Behfar A, Terzic A. Brief Report: Ventricular Remodeling in Ischemic Heart Failure Stratifies Responders to Stem Cell Therapy. Stem Cells Translational Medicine. PMID 31373782 DOI: 10.1002/Sctm.19-0149 |
0.459 |
|
| 2019 |
Neri T, Hiriart E, van Vliet PP, Faure E, Norris RA, Farhat B, Jagla B, Lefrancois J, Sugi Y, Moore-Morris T, Zaffran S, Faustino RS, Zambon AC, Desvignes JP, Salgado D, ... ... Terzic A, et al. Human pre-valvular endocardial cells derived from pluripotent stem cells recapitulate cardiac pathophysiological valvulogenesis. Nature Communications. 10: 1929. PMID 31028265 DOI: 10.1038/S41467-019-09459-5 |
0.435 |
|
| 2018 |
Singh RD, Hillestad M, Livia C, Li M, Alekseev A, Witt TA, Stalboerger PG, Yamada S, Terzic A, Behfar A. M3RNA Drives Targeted Gene Delivery in Acute Myocardial Infarction. Tissue Engineering. Part A. PMID 30047313 DOI: 10.1089/Ten.Tea.2017.0445 |
0.336 |
|
| 2018 |
Musunuru K, Sheikh F, Gupta RM, Houser SR, Maher KO, Milan DJ, Terzic A, Wu JC. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association. Circulation. Genomic and Precision Medicine. 11: e000043. PMID 29874173 DOI: 10.1161/HCG.0000000000000043 |
0.316 |
|
| 2018 |
Bartunek J, Terzic A, Behfar A, Wijns W. Clinical Experience With Regenerative Therapy in Heart Failure: Advancing Care With Cardiopoietic Stem Cell Interventions. Circulation Research. 122: 1344-1346. PMID 29748365 DOI: 10.1161/Circresaha.118.312753 |
0.452 |
|
| 2018 |
Houdek MT, Wyles CC, Collins MS, Howe BM, Terzic A, Behfar A, Sierra RJ. Reply to the Letter to the Editor: Stem Cells Combined With Platelet-rich Plasma Effectively Treat Corticosteroid-induced Osteonecrosis of the Hip: A Prospective Study. Clinical Orthopaedics and Related Research. PMID 29601399 DOI: 10.1007/S11999.0000000000000284 |
0.311 |
|
| 2018 |
Houdek MT, Wyles CC, Collins MS, Howe BM, Terzic A, Behfar A, Sierra RJ. Stem Cells Combined With Platelet-rich Plasma Effectively Treat Corticosteroid-induced Osteonecrosis of the Hip: A Prospective Study. Clinical Orthopaedics and Related Research. 476: 388-397. PMID 29529674 DOI: 10.1007/S11999.0000000000000033 |
0.303 |
|
| 2018 |
Sherman W, Bartunek J, Dolatabadi D, Sanz-Ruiz R, Beleslin B, Wojakowski W, Heyndrickx G, Kimpalou JZ, Waldman SA, Laarman GJ, Seron A, Behfar A, Latere JP, Terzic A, Wijns W, et al. First-in-Human Use of a Retention-Enhanced Catheter for Endomyocardial Cell Delivery. Jacc. Cardiovascular Interventions. 11: 412-414. PMID 29471956 DOI: 10.1016/J.Jcin.2017.10.036 |
0.329 |
|
| 2018 |
Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasché P, Pinto FJ, Simari RD, ... ... Terzic A, et al. Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine. Circulation Research. 122: 199-201. PMID 29348246 DOI: 10.1161/Circresaha.117.312099 |
0.318 |
|
| 2018 |
Bulatovic I, Folmes C, Vuckovic I, Zhang S, Osterholm C, Terzic A, Grinnemo KH. P84Metabolomic profiling of human fetal cardiac mesenchymal stromal cells Cardiovascular Research. 114: S22-S22. DOI: 10.1093/Cvr/Cvy060.048 |
0.363 |
|
| 2017 |
Terzic A, Behfar A. Posology for Regenerative Therapy. Circulation Research. 121: 1213-1215. PMID 29122941 DOI: 10.1161/Circresaha.117.312074 |
0.378 |
|
| 2017 |
Teerlink JR, Metra M, Filippatos GS, Davison BA, Bartunek J, Terzic A, Gersh BJ, Povsic TJ, Henry TD, Alexandre B, Homsy C, Edwards C, Seron A, Wijns W, Cotter G, et al. Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study. European Journal of Heart Failure. PMID 28560782 DOI: 10.1002/Ejhf.898 |
0.427 |
|
| 2016 |
Bartunek J, Terzic A, Davison BA, Filippatos GS, Radovanovic S, Beleslin B, Merkely B, Musialek P, Wojakowski W, Andreka P, Horvath IG, Katz A, Dolatabadi D, El Nakadi B, Arandjelovic A, et al. Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial. European Heart Journal. PMID 28025189 DOI: 10.1093/Eurheartj/Ehw543 |
0.406 |
|
| 2016 |
Perales-Clemente E, Cook AN, Evans JM, Roellinger S, Secreto F, Emmanuele V, Oglesbee D, Mootha VK, Hirano M, Schon EA, Terzic A, Nelson TJ. Natural underlying mtDNA heteroplasmy as a potential source of intra-person hiPSC variability. The Embo Journal. PMID 27436875 DOI: 10.15252/Embj.201694892 |
0.31 |
|
| 2016 |
Houdek MT, Wyles CC, Stalboerger PG, Terzic A, Behfar A, Moran SL. Collagen and Fractionated Platelet-Rich Plasma Scaffold for Dermal Regeneration. Plastic and Reconstructive Surgery. 137: 1498-506. PMID 27119924 DOI: 10.1097/Prs.0000000000002094 |
0.327 |
|
| 2016 |
Wyles SP, Hrstka SC, Reyes S, Terzic A, Olson TM, Nelson TJ. Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model. Clinical and Translational Science. PMID 27105042 DOI: 10.1111/Cts.12393 |
0.326 |
|
| 2016 |
Terzic A, Behfar A. Stem cell therapy for heart failure: Ensuring regenerative proficiency. Trends in Cardiovascular Medicine. 26: 395-404. PMID 27020904 DOI: 10.1016/J.Tcm.2016.01.003 |
0.456 |
|
| 2016 |
El Khatib MM, Ohmine S, Jacobus EJ, Tonne JM, Morsy SG, Holditch SJ, Schreiber CA, Uetsuka K, Fusaki N, Wigle DA, Terzic A, Kudva YC, Ikeda Y. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration. Stem Cells Translational Medicine. PMID 26987352 DOI: 10.5966/Sctm.2015-0017 |
0.33 |
|
| 2016 |
Li X, Campbell KA, Biendarra SM, Terzic A, Nelson TJ. Mapping transcriptome profiles of in vitro iPSC-derived cardiac differentiation to in utero heart development. Genomics Data. 7: 129-30. PMID 26981387 DOI: 10.1016/J.Gdata.2015.12.022 |
0.381 |
|
| 2016 |
Folmes CD, Ma H, Mitalipov S, Terzic A. Mitochondria in pluripotent stem cells: stemness regulators and disease targets. Current Opinion in Genetics & Development. 38: 1-7. PMID 26953561 DOI: 10.1016/J.Gde.2016.02.001 |
0.406 |
|
| 2016 |
Folmes CD, Terzic A. Energy metabolism in the acquisition and maintenance of stemness. Seminars in Cell & Developmental Biology. 52: 68-75. PMID 26868758 DOI: 10.1016/J.Semcdb.2016.02.010 |
0.373 |
|
| 2016 |
Faustino RS, Behfar A, Groenendyk J, Wyles SP, Niederlander N, Ramirez SR, Puceat M, Michalak M, Terzic A, Perez-Terzic C. Calreticulin secures calcium-dependent nuclear pore competency required for cardiogenesis. Journal of Molecular and Cellular Cardiology. PMID 26826378 DOI: 10.1016/J.Yjmcc.2016.01.022 |
0.369 |
|
| 2016 |
Terzic A, Behfar A, Filippatos G. Clinical development plan for regenerative therapy in heart failure. European Journal of Heart Failure. 18: 142-4. PMID 26800140 DOI: 10.1002/Ejhf.479 |
0.34 |
|
| 2016 |
Bartunek J, Davison B, Sherman W, Povsic T, Henry TD, Gersh B, Metra M, Filippatos G, Hajjar R, Behfar A, Homsy C, Cotter G, Wijns W, Tendera M, Terzic A. Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design. European Journal of Heart Failure. 18: 160-8. PMID 26662998 DOI: 10.1002/Ejhf.434 |
0.43 |
|
| 2016 |
Behfar A, Gersh B, Terzic A. Repetition rescues regenerative reserve. European Heart Journal. 37: 1667-70. PMID 26637833 DOI: 10.1093/Eurheartj/Ehv596 |
0.324 |
|
| 2015 |
Wyles SP, Li X, Hrstka SC, Reyes S, Oommen S, Beraldi R, Edwards J, Terzic A, Olson TM, Nelson TJ. Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells. Human Molecular Genetics. PMID 26604136 DOI: 10.1093/Hmg/Ddv468 |
0.327 |
|
| 2015 |
Campbell KA, Terzic A, Nelson TJ. Induced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discovery. Regenerative Medicine. 10: 773-83. PMID 26439809 DOI: 10.2217/Rme.15.41 |
0.358 |
|
| 2015 |
Houdek MT, Wyles CC, Packard BD, Terzic A, Behfar A, Sierra RJ. Decreased Osteogenic Activity of Mesenchymal Stem Cells in Patients With Corticosteroid-Induced Osteonecrosis of the Femoral Head. The Journal of Arthroplasty. PMID 26404846 DOI: 10.1016/J.Arth.2015.08.017 |
0.357 |
|
| 2015 |
Campbell KA, Li X, Biendarra SM, Terzic A, Nelson TJ. Nos3(-/-) iPSCs model concordant signatures of in utero cardiac pathogenesis. Journal of Molecular and Cellular Cardiology. PMID 26344701 DOI: 10.1016/J.Yjmcc.2015.08.021 |
0.389 |
|
| 2015 |
Banovic M, Loncar Z, Behfar A, Vanderheyden M, Beleslin B, Zeiher A, Metra M, Terzic A, Bartunek J. Endpoints in stem cell trials in ischemic heart failure. Stem Cell Research & Therapy. 6: 159. PMID 26319401 DOI: 10.1186/S13287-015-0143-9 |
0.408 |
|
| 2015 |
O'Brien T, Creane M, Windebank AJ, Terzic A, Dietz AB. Translating stem cell research to the clinic: a primer on translational considerations for your first stem cell protocol. Stem Cell Research & Therapy. 6: 146. PMID 26296990 DOI: 10.1186/S13287-015-0145-7 |
0.4 |
|
| 2015 |
Faustino RS, Wyles SP, Groenendyk J, Michalak M, Terzic A, Perez-Terzic C. Systems biology surveillance decrypts pathological transcriptome remodeling. Bmc Systems Biology. 9: 36. PMID 26179794 DOI: 10.1186/S12918-015-0177-8 |
0.334 |
|
| 2015 |
Ma H, Folmes CD, Wu J, Morey R, Mora-Castilla S, Ocampo A, Ma L, Poulton J, Wang X, Ahmed R, Kang E, Lee Y, Hayama T, Li Y, Van Dyken C, ... ... Terzic A, et al. Metabolic rescue in pluripotent cells from patients with mtDNA disease. Nature. PMID 26176921 DOI: 10.1038/Nature14546 |
0.335 |
|
| 2015 |
Wyles CC, Houdek MT, Crespo-Diaz RJ, Norambuena GA, Stalboerger PG, Terzic A, Behfar A, Sierra RJ. Adipose-derived Mesenchymal Stem Cells Are Phenotypically Superior for Regeneration in the Setting of Osteonecrosis of the Femoral Head. Clinical Orthopaedics and Related Research. 473: 3080-90. PMID 26070774 DOI: 10.1007/S11999-015-4385-8 |
0.753 |
|
| 2015 |
Cabral-Teixeira J, Martinez-Fernandez A, Cai W, Terzic A, Mercola M, Willems E. Cholesterol-derived glucocorticoids control early fate specification in embryonic stem cells. Stem Cell Research. 15: 88-95. PMID 26024790 DOI: 10.1016/J.Scr.2015.04.010 |
0.389 |
|
| 2015 |
Crespo-Diaz R, Yamada S, Bartunek J, Perez-Terzic C, de Waele P, Mauën S, Terzic A, Behfar A. Cardiopoietic index predicts heart repair fitness of patient-derived stem cells. Biomarkers in Medicine. 9: 639-49. PMID 26014833 DOI: 10.2217/Bmm.15.31 |
0.778 |
|
| 2015 |
Yamada S, Arrell DK, Martinez-Fernandez A, Behfar A, Kane GC, Perez-Terzic CM, Crespo-Diaz RJ, McDonald RJ, Wyles SP, Zlatkovic-Lindor J, Nelson TJ, Terzic A. Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS Cardiomyopathy. Journal of the American Heart Association. 4. PMID 25964205 DOI: 10.1161/Jaha.114.001614 |
0.749 |
|
| 2015 |
Bansal A, Pandey MK, Demirhan YE, Nesbitt JJ, Crespo-Diaz RJ, Terzic A, Behfar A, DeGrado TR. Novel (89)Zr cell labeling approach for PET-based cell trafficking studies. Ejnmmi Research. 5: 19. PMID 25918673 DOI: 10.1186/S13550-015-0098-Y |
0.721 |
|
| 2015 |
Nemutlu E, Zhang S, Xu YZ, Terzic A, Zhong L, Dzeja PD, Cha YM. Cardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure. Journal of Cardiac Failure. 21: 460-9. PMID 25911126 DOI: 10.1016/J.Cardfail.2015.04.005 |
0.329 |
|
| 2015 |
Oommen S, Yamada S, Cantero Peral S, Campbell KA, Bruinsma ES, Terzic A, Nelson TJ. Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload. Stem Cell Research & Therapy. 6: 50. PMID 25890300 DOI: 10.1186/S13287-015-0044-Y |
0.402 |
|
| 2015 |
Behfar A, Terzic A. Stem cells versus senescence: the yin and yang of cardiac health. Journal of the American College of Cardiology. 65: 148-50. PMID 25593055 DOI: 10.1016/J.Jacc.2014.10.041 |
0.398 |
|
| 2015 |
Cantero Peral S, Burkhart HM, Oommen S, Yamada S, Nyberg SL, Li X, O'Leary PW, Terzic A, Cannon BC, Nelson TJ. Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system. Stem Cells Translational Medicine. 4: 195-206. PMID 25561683 DOI: 10.5966/Sctm.2014-0195 |
0.379 |
|
| 2015 |
Farouz Y, Chen Y, Terzic A, Menasché P. Concise review: growing hearts in the right place: on the design of biomimetic materials for cardiac stem cell differentiation. Stem Cells (Dayton, Ohio). 33: 1021-35. PMID 25537366 DOI: 10.1002/Stem.1929 |
0.437 |
|
| 2015 |
Wyles SP, Faustino RS, Li X, Terzic A, Nelson TJ. Systems-based technologies in profiling the stem cell molecular framework for cardioregenerative medicine. Stem Cell Reviews. 11: 501-10. PMID 25218144 DOI: 10.1007/S12015-014-9557-5 |
0.437 |
|
| 2015 |
Li X, Wyles S, Hrstka SC, Kocher JPA, Terzic A, Olson TM, Nelson TJ. Time course transcriptome data analysis for in vitro modeling of dilated cardiomyopathy using patient-derived induced pluripotent stem cells Bmc Bioinformatics. 16. DOI: 10.1186/1471-2105-16-S15-P8 |
0.389 |
|
| 2015 |
Hillestad ML, Boroumand S, Behfar A, Terzic A. 192. Regulated Atrial Natriuretic Peptide Expression with a Novel Spatiotemporal AAV Vector Cassette for Treating Congestive Heart Failure Molecular Therapy. 23: S76-S77. DOI: 10.1016/S1525-0016(16)33797-2 |
0.322 |
|
| 2015 |
Koski A, Ma H, Folmes CD, Wu J, Morey R, Mora-Castilla S, Ocampo A, Ma L, Poulton J, Wang X, Ahmed R, Kang E, Lee Y, Hayama T, Li Y, ... ... Terzic A, et al. Genetically and metabolically corrected pluripotent stem cells from patients with mtDNA disease Mitochondrion. 24: S38. DOI: 10.1016/J.Mito.2015.07.106 |
0.327 |
|
| 2014 |
Folmes CD, Terzic A. Metabolic determinants of embryonic development and stem cell fate. Reproduction, Fertility, and Development. 27: 82-8. PMID 25472047 DOI: 10.1071/Rd14383 |
0.384 |
|
| 2014 |
Behfar A, Terzic A. Stem cell in the rough: repair quotient mined out of a bone marrow niche. Circulation Research. 115: 814-6. PMID 25342767 DOI: 10.1161/Circresaha.114.305075 |
0.451 |
|
| 2014 |
Behfar A, Terzic A, Perez-Terzic CM. Regenerative principles enrich cardiac rehabilitation practice. American Journal of Physical Medicine & Rehabilitation / Association of Academic Physiatrists. 93: S169-75. PMID 25313663 DOI: 10.1097/Phm.0000000000000147 |
0.431 |
|
| 2014 |
Folmes CD, Terzic A. Stem cell lineage specification: you become what you eat. Cell Metabolism. 20: 389-91. PMID 25185944 DOI: 10.1016/J.Cmet.2014.08.006 |
0.376 |
|
| 2014 |
Behfar A, Crespo-Diaz R, Terzic A, Gersh BJ. Reply: Translation of regenerative technologies into clinical paradigms. Nature Reviews. Cardiology. 11: 553-4. PMID 25093433 DOI: 10.1038/Nrcardio.2014.9-C2 |
0.702 |
|
| 2014 |
Martinez-Fernandez A, Nelson TJ, Reyes S, Alekseev AE, Secreto F, Perez-Terzic C, Beraldi R, Sung HK, Nagy A, Terzic A. iPS cell-derived cardiogenicity is hindered by sustained integration of reprogramming transgenes. Circulation. Cardiovascular Genetics. 7: 667-76. PMID 25077947 DOI: 10.1161/Circgenetics.113.000298 |
0.38 |
|
| 2014 |
Wyles SP, Yamada S, Oommen S, Maleszewski JJ, Beraldi R, Martinez-Fernandez A, Terzic A, Nelson TJ. Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy. Stem Cells and Development. 23: 2274-82. PMID 25036735 DOI: 10.1089/Scd.2014.0259 |
0.447 |
|
| 2014 |
Yamada S, Terzic A. Reparative resynchronization in ischemic heart failure: an emerging strategy. Expert Opinion On Biological Therapy. 14: 1055-60. PMID 24840208 DOI: 10.1517/14712598.2014.922536 |
0.419 |
|
| 2014 |
Li X, Martinez-Fernandez A, Hartjes KA, Kocher JPA, Olson TM, Terzic A, Nelson TJ. Transcriptional atlas of cardiogenesis maps congenital heart disease interactome Physiological Genomics. 46: 482-495. PMID 24803680 DOI: 10.1152/Physiolgenomics.00015.2014 |
0.351 |
|
| 2014 |
Hartjes KA, Li X, Martinez-Fernandez A, Roemmich AJ, Larsen BT, Terzic A, Nelson TJ. Selection via pluripotency-related transcriptional screen minimizes the influence of somatic origin on iPSC differentiation propensity. Stem Cells (Dayton, Ohio). 32: 2350-9. PMID 24802033 DOI: 10.1002/Stem.1734 |
0.371 |
|
| 2014 |
Terzic A, Behfar A. Regenerative heart failure therapy headed for optimization. European Heart Journal. 35: 1231-4. PMID 24670713 DOI: 10.1093/Eurheartj/Ehu117 |
0.408 |
|
| 2014 |
Barbato E, Lara-Pezzi E, Stolen C, Taylor A, Barton PJ, Bartunek J, Iaizzo P, Judge DP, Kirshenbaum L, Blaxall BC, Terzic A, Hall JL. Advances in induced pluripotent stem cells, genomics, biomarkers, and antiplatelet therapy highlights of the year in JCTR 2013. Journal of Cardiovascular Translational Research. 7: 518-25. PMID 24659088 DOI: 10.1007/S12265-014-9555-7 |
0.366 |
|
| 2014 |
Holditch SJ, Terzic A, Ikeda Y. Concise review: pluripotent stem cell-based regenerative applications for failing β-cell function. Stem Cells Translational Medicine. 3: 653-61. PMID 24646490 DOI: 10.5966/Sctm.2013-0184 |
0.401 |
|
| 2014 |
Behfar A, Crespo-Diaz R, Terzic A, Gersh BJ. Cell therapy for cardiac repair--lessons from clinical trials. Nature Reviews. Cardiology. 11: 232-46. PMID 24594893 DOI: 10.1038/Nrcardio.2014.9 |
0.778 |
|
| 2014 |
Beraldi R, Li X, Fernandez AM, Reyes S, Secreto F, Terzic A, Olson TM, Nelson TJ. Rbm20-deficient cardiogenesis reveals early disruption of RNA processing and sarcomere remodeling establishing a developmental etiology for dilated cardiomyopathy Human Molecular Genetics. 23: 3779-3791. PMID 24584570 DOI: 10.1093/Hmg/Ddu091 |
0.41 |
|
| 2014 |
Li X, Martinez-Fernandez A, Theis J, Kocher JP, Terzic A, Olson T, Nelson TJ. Prioritizing disease-related genes and pathways by integrating patient-specific iPSC-derived RNA-seq and whole genome sequencing in hypoplastic left heart syndrome Bmc Bioinformatics. 15. DOI: 10.1186/1471-2105-15-S10-P7 |
0.369 |
|
| 2014 |
Roy D, He X, Khurana A, Mondal S, Jung D, Kim S, Dierks T, Folmes C, Terzic A, Shridhar V. Abstract 2439: HSulf-1 loss in ovarian cancer cells induces lipid droplet biogenesis Cancer Research. 74: 2439-2439. DOI: 10.1158/1538-7445.Am2014-2439 |
0.322 |
|
| 2014 |
Passegue E, Teitell M, Ding S, Rando T, Belmonte JCI, Ramalho-Santos M, Terzic A, Brunet A, Chandel NS, Bonnet D, Jasper H. Stem cell energetics Cell Metabolism. 20: 922-925. DOI: 10.1016/J.Cmet.2014.11.007 |
0.371 |
|
| 2013 |
Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, Nakadi BE, Banovic M, Beleslin B, Vrolix M, Legrand V, Vrints C, Vanoverschelde JL, Crespo-Diaz R, Homsy C, ... ... Terzic A, et al. Erratum: Cardiopoietic stem cell therapy in heart failure: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) Multicenter randomized trial with lineage-specified biologics (Journal of the American College of Cardiology (2013) 61 (2329-2338)) Journal of the American College of Cardiology. 62: 2457-2458. PMID 29078960 DOI: 10.1016/J.Jacc.2013.09.008 |
0.769 |
|
| 2013 |
Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, El Nakadi B, Banovic M, Beleslin B, Vrolix M, Legrand V, Vrints C, Vanoverschelde JL, Crespo-Diaz R, Homsy C, ... ... Terzic A, et al. Reply: The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE). Journal of the American College of Cardiology. 62: 2454-6. PMID 24355591 DOI: 10.1016/J.Jacc.2013.09.014 |
0.763 |
|
| 2013 |
Behfar A, Latere JP, Bartunek J, Homsy C, Daro D, Crespo-Diaz RJ, Stalboerger PG, Steenwinckel V, Seron A, Redfield MM, Terzic A. Optimized delivery system achieves enhanced endomyocardial stem cell retention Circulation: Cardiovascular Interventions. 6: 710-718. PMID 24326777 DOI: 10.1161/Circinterventions.112.000422 |
0.77 |
|
| 2013 |
Yamada S, Arrell DK, Kane GC, Nelson TJ, Perez-Terzic CM, Behfar A, Purushothaman S, Prinzen FW, Auricchio A, Terzic A. Mechanical dyssynchrony precedes QRS widening in ATP-sensitive K⁺ channel-deficient dilated cardiomyopathy. Journal of the American Heart Association. 2: e000410. PMID 24308936 DOI: 10.1161/Jaha.113.000410 |
0.361 |
|
| 2013 |
Martinez-Fernandez A, Li X, Hartjes KA, Terzic A, Nelson TJ. Natural cardiogenesis-based template predicts cardiogenic potential of induced pluripotent stem cell lines. Circulation. Cardiovascular Genetics. 6: 462-71. PMID 24036272 DOI: 10.1161/Circgenetics.113.000045 |
0.404 |
|
| 2013 |
Suresh R, Chiriac A, Goel K, Villarraga HR, Lopez-Jimenez F, Thomas RJ, Terzic A, Nelson TJ, Perez-Terzic C. CXCR4+ and FLK-1+ identify circulating cells associated with improved cardiac function in patients following myocardial infarction. Journal of Cardiovascular Translational Research. 6: 787-97. PMID 23934537 DOI: 10.1007/S12265-013-9502-Z |
0.373 |
|
| 2013 |
Folmes CD, Arrell DK, Zlatkovic-Lindor J, Martinez-Fernandez A, Perez-Terzic C, Nelson TJ, Terzic A. Metabolome and metaboproteome remodeling in nuclear reprogramming. Cell Cycle (Georgetown, Tex.). 12: 2355-65. PMID 23839047 DOI: 10.4161/Cc.25509 |
0.363 |
|
| 2013 |
Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, El Nakadi B, Banovic M, Beleslin B, Vrolix M, Legrand V, Vrints C, Vanoverschelde JL, Crespo-Diaz R, Homsy C, ... ... Terzic A, et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. Journal of the American College of Cardiology. 61: 2329-38. PMID 23583246 DOI: 10.1016/J.Jacc.2013.02.071 |
0.771 |
|
| 2013 |
Yamada S, Nelson TJ, Kane GC, Martinez-Fernandez A, Crespo-Diaz RJ, Ikeda Y, Perez-Terzic C, Terzic A. Induced pluripotent stem cell intervention rescues ventricular wall motion disparity, achieving biological cardiac resynchronization post-infarction. The Journal of Physiology. 591: 4335-49. PMID 23568891 DOI: 10.1113/Jphysiol.2013.252288 |
0.77 |
|
| 2013 |
Folmes CD, Martinez-Fernandez A, Perales-Clemente E, Li X, McDonald A, Oglesbee D, Hrstka SC, Perez-Terzic C, Terzic A, Nelson TJ. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS. Stem Cells (Dayton, Ohio). 31: 1298-308. PMID 23553816 DOI: 10.1002/Stem.1389 |
0.354 |
|
| 2013 |
Folmes CD, Park S, Terzic A. Lipid metabolism greases the stem cell engine. Cell Metabolism. 17: 153-5. PMID 23395162 DOI: 10.1016/J.Cmet.2013.01.010 |
0.355 |
|
| 2013 |
Folmes CD, Martinez-Fernandez A, Faustino RS, Yamada S, Perez-Terzic C, Nelson TJ, Terzic A. Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells. Journal of Cardiovascular Translational Research. 6: 10-21. PMID 23247633 DOI: 10.1007/S12265-012-9431-2 |
0.353 |
|
| 2013 |
Baker DJ, Dawlaty MM, Wijshake T, Jeganathan KB, Malureanu L, van Ree JH, Crespo-Diaz R, Reyes S, Seaburg L, Shapiro V, Behfar A, Terzic A, van de Sluis B, van Deursen JM. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nature Cell Biology. 15: 96-102. PMID 23242215 DOI: 10.1038/Ncb2643 |
0.704 |
|
| 2013 |
Thatava T, Kudva YC, Edukulla R, Squillace K, De Lamo JG, Khan YK, Sakuma T, Ohmine S, Terzic A, Ikeda Y. Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 228-39. PMID 23183535 DOI: 10.1038/Mt.2012.245 |
0.37 |
|
| 2012 |
Nemutlu E, Zhang S, Juranic NO, Terzic A, Macura S, Dzeja P. 18O-assisted dynamic metabolomics for individualized diagnostics and treatment of human diseases. Croatian Medical Journal. 53: 529-34. PMID 23275318 DOI: 10.3325/Cmj.2012.53.529 |
0.306 |
|
| 2012 |
Smith AJ, Nelson NG, Oommen S, Hartjes KA, Folmes CD, Terzic A, Nelson TJ. Apoptotic susceptibility to DNA damage of pluripotent stem cells facilitates pharmacologic purging of teratoma risk. Stem Cells Translational Medicine. 1: 709-18. PMID 23197662 DOI: 10.5966/Sctm.2012-0066 |
0.404 |
|
| 2012 |
Folmes CD, Dzeja PP, Nelson TJ, Terzic A. Metabolic plasticity in stem cell homeostasis and differentiation. Cell Stem Cell. 11: 596-606. PMID 23122287 DOI: 10.1016/J.Stem.2012.10.002 |
0.388 |
|
| 2012 |
Strege P, Beyder A, Bernard C, Crespo-Diaz R, Behfar A, Terzic A, Ackerman M, Farrugia G. Ranolazine inhibits shear sensitivity of endogenous Na+ current and spontaneous action potentials in HL-1 cells. Channels (Austin, Tex.). 6: 457-62. PMID 23018927 DOI: 10.4161/Chan.22017 |
0.725 |
|
| 2012 |
Folmes CD, Nelson TJ, Dzeja PP, Terzic A. Energy metabolism plasticity enables stemness programs. Annals of the New York Academy of Sciences. 1254: 82-9. PMID 22548573 DOI: 10.1111/J.1749-6632.2012.06487.X |
0.388 |
|
| 2012 |
Folmes CD, Dzeja PP, Nelson TJ, Terzic A. Mitochondria in control of cell fate. Circulation Research. 110: 526-9. PMID 22343555 DOI: 10.1161/Res.0B013E31824Ae5C1 |
0.371 |
|
| 2011 |
Folmes CD, Nelson TJ, Terzic A. Energy metabolism in nuclear reprogramming. Biomarkers in Medicine. 5: 715-29. PMID 22103608 DOI: 10.2217/Bmm.11.87 |
0.372 |
|
| 2011 |
Waldman SA, Terzic A. Patient-centric clinical pharmacology advances the path to personalized medicine. Biomarkers in Medicine. 5: 697-700. PMID 22103605 DOI: 10.2217/Bmm.11.78 |
0.301 |
|
| 2011 |
Hall JL, Terzic A. Heart failure transcriptome: when discoveries change practice? Circulation. Cardiovascular Genetics. 4: 469-71. PMID 22010160 DOI: 10.1161/Circgenetics.111.961367 |
0.345 |
|
| 2011 |
Terzic A, Alekseev AE, Yamada S, Reyes S, Olson TM. Advances in cardiac ATP-Sensitive K+ channelopathies from molecules to populations Circulation: Arrhythmia and Electrophysiology. 4: 577-585. PMID 21846889 DOI: 10.1161/Circep.110.957662 |
0.358 |
|
| 2011 |
Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, Dzeja PP, Ikeda Y, Perez-Terzic C, Terzic A. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metabolism. 14: 264-71. PMID 21803296 DOI: 10.1016/J.Cmet.2011.06.011 |
0.377 |
|
| 2011 |
Dzeja PP, Chung S, Faustino RS, Behfar A, Terzic A. Developmental enhancement of adenylate kinase-AMPK metabolic signaling axis supports stem cell cardiac differentiation. Plos One. 6: e19300. PMID 21556322 DOI: 10.1371/Journal.Pone.0019300 |
0.346 |
|
| 2011 |
Nelson TJ, Terzic A. Induced pluripotent stem cells: an emerging theranostics platform. Clinical Pharmacology & Therapeutics. 89: 648-650. PMID 21512525 DOI: 10.1038/Clpt.2010.304 |
0.43 |
|
| 2011 |
Arrell DK, Zlatkovic Lindor J, Yamada S, Terzic A. KATP channel-dependent metaboproteome decoded: Systems approaches to heart failure prediction, diagnosis, and therapy Cardiovascular Research. 90: 258-266. PMID 21321057 DOI: 10.1093/Cvr/Cvr046 |
0.42 |
|
| 2011 |
Martinez-Fernandez A, Nelson TJ, Terzic A. Nuclear reprogramming strategy modulates differentiation potential of induced pluripotent stem cells. Journal of Cardiovascular Translational Research. 4: 131-7. PMID 21207217 DOI: 10.1007/S12265-010-9250-2 |
0.413 |
|
| 2011 |
Crespo-Diaz R, Behfar A, Butler GW, Padley DJ, Sarr MG, Bartunek J, Dietz AB, Terzic A. Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplantation. 20: 797-811. PMID 21092406 DOI: 10.3727/096368910X543376 |
0.738 |
|
| 2011 |
Bardelli S, Astori G, Sürder D, Tallone T, Terzic A, Soldati G, Moccetti T. Stem cell update: highlights from the 2010 Lugano Stem Cell Meeting. Journal of Cardiovascular Translational Research. 4: 192-199. PMID 21052883 DOI: 10.1007/S12265-010-9232-4 |
0.437 |
|
| 2011 |
Thatava T, Nelson TJ, Edukulla R, Sakuma T, Ohmine S, Tonne JM, Yamada S, Kudva Y, Terzic A, Ikeda Y. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny. Gene Therapy. 18: 283-93. PMID 21048796 DOI: 10.1038/Gt.2010.145 |
0.325 |
|
| 2011 |
Yamada S, Nelson TJ, Martinez-Fernandez AJ, Kane GC, Terzic A. Induced Pluripotent Stem Cell Therapy Synchronizes Global And Regional Myocardial Function Post-Infarction Journal of the American College of Cardiology. 57. DOI: 10.1016/S0735-1097(11)60984-4 |
0.392 |
|
| 2010 |
Nelson TJ, Martinez-Fernandez A, Yamada S, Ikeda Y, Perez-Terzic C, Terzic A. Induced pluripotent stem cells: advances to applications. Stem Cells and Cloning : Advances and Applications. 3: 29-37. PMID 21165156 DOI: 10.2147/SCCAA.S4954 |
0.326 |
|
| 2010 |
Nelson TJ, Martinez-Fernandez A, Terzic A. Induced pluripotent stem cells: developmental biology to regenerative medicine. Nature Reviews. Cardiology. 7: 700-10. PMID 20956984 DOI: 10.1038/Nrcardio.2010.159 |
0.453 |
|
| 2010 |
Terzic A, Perez-Terzic C. Cell therapy for heart failure. Revista Espanola De Cardiologia. 63: 1117-1119. PMID 20875349 DOI: 10.1016/S1885-5857(10)70223-1 |
0.433 |
|
| 2010 |
Chiriac A, Terzic A, Park S, Ikeda Y, Faustino R, Nelson TJ. SDF-1-enhanced cardiogenesis requires CXCR4 induction in pluripotent stem cells. Journal of Cardiovascular Translational Research. 3: 674-82. PMID 20842469 DOI: 10.1007/S12265-010-9219-1 |
0.416 |
|
| 2010 |
Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C, Gaussin V, Homsy C, Bartunek J, Terzic A. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. Journal of the American College of Cardiology. 56: 721-34. PMID 20723802 DOI: 10.1016/J.Jacc.2010.03.066 |
0.758 |
|
| 2010 |
Behfar A, Crespo-Diaz R, Nelson TJ, Terzic A, Gersh BJ. Stem cells: clinical trials results the end of the beginning or the beginning of the end? Cardiovascular & Hematological Disorders Drug Targets. 10: 186-201. PMID 20678060 DOI: 10.2174/1871529X11006030186 |
0.788 |
|
| 2010 |
Terzic A, Perez-Terzic C. Channelopathies: Decoding Disease Pathogenesis Science Translational Medicine. 2. PMID 20668296 DOI: 10.1126/Scitranslmed.3001433 |
0.307 |
|
| 2010 |
Zlatkovic-Lindor J, Arrell DK, Yamada S, Nelson TJ, Terzic A. ATP-sensitive K(+) channel-deficient dilated cardiomyopathy proteome remodeled by embryonic stem cell therapy. Stem Cells (Dayton, Ohio). 28: 1355-67. PMID 20572010 DOI: 10.1002/Stem.465 |
0.484 |
|
| 2010 |
Faustino RS, Chiriac A, Niederlander NJ, Nelson TJ, Behfar A, Mishra PK, Macura S, Michalak M, Terzic A, Perez-Terzic C. Decoded calreticulin-deficient embryonic stem cell transcriptome resolves latent cardiophenotype. Stem Cells (Dayton, Ohio). 28: 1281-91. PMID 20506533 DOI: 10.1002/Stem.447 |
0.424 |
|
| 2010 |
Bartunek J, Vanderheyden M, Hill J, Terzic A. Cells as biologics for cardiac repair in ischaemic heart failure Heart. 96: 792-800. PMID 20448133 DOI: 10.1136/Hrt.2007.139394 |
0.461 |
|
| 2010 |
Behfar A, Terzic A. Mesenchymal stem cells: engineering regeneration. Clinical and Translational Science. 1: 34-5. PMID 20443816 DOI: 10.1111/J.1752-8062.2008.00024.X |
0.361 |
|
| 2010 |
Chiriac A, Nelson TJ, Faustino RS, Behfar A, Terzic A. Cardiogenic induction of pluripotent stem cells streamlined through a conserved SDF-1/VEGF/BMP2 integrated network. Plos One. 5: e9943. PMID 20376342 DOI: 10.1371/Journal.Pone.0009943 |
0.401 |
|
| 2010 |
Dib N, Menasche P, Bartunek JJ, Zeiher AM, Terzic A, Chronos NA, Henry TD, Peters NS, Fernández-Avilés F, Yacoub M, Sanborn TA, Demaria A, Schatz RA, Taylor DA, Fuchs S, et al. Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research. Jacc. Cardiovascular Interventions. 3: 265-75. PMID 20298983 DOI: 10.1016/J.Jcin.2009.12.013 |
0.349 |
|
| 2010 |
Martinez-Fernandez A, Nelson TJ, Ikeda Y, Terzic A. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells. Journal of Cardiovascular Translational Research. 3: 13-23. PMID 20221419 DOI: 10.1007/S12265-009-9150-5 |
0.424 |
|
| 2010 |
Zhao Q, Beck A, Vitale JM, Schneider JS, Terzic A, Fraidenraich D. Rescue of developmental defects by blastocyst stem cell injection: towards elucidation of neomorphic corrective pathways. Journal of Cardiovascular Translational Research. 3: 66. PMID 20151025 DOI: 10.1007/S12265-009-9140-7 |
0.359 |
|
| 2010 |
Chung S, Arrell DK, Faustino RS, Terzic A, Dzeja PP. Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation. Journal of Molecular and Cellular Cardiology. 48: 725-34. PMID 20045004 DOI: 10.1016/J.Yjmcc.2009.12.014 |
0.409 |
|
| 2010 |
Olson TM, Terzic A. Human KATP channelopathies: Diseases of metabolic homeostasis Pflugers Archiv European Journal of Physiology. 460: 295-306. PMID 20033705 DOI: 10.1007/S00424-009-0771-Y |
0.343 |
|
| 2010 |
Folmes C, Martinez-Fernandez A, Terzic A, Nelson TJ. Pluripotent Stem Cells and Mitochondrial Remodeling Free Radical Biology and Medicine. 49. DOI: 10.1016/J.Freeradbiomed.2010.10.674 |
0.382 |
|
| 2009 |
Waldman SA, Kraft WK, Nelson TJ, Terzic A. Clinical pharmacology: a paradigm for individualized medicine. Biomarkers in Medicine. 3: 679-684. PMID 20477706 DOI: 10.2217/Bmm.09.76 |
0.31 |
|
| 2009 |
Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A. Cardiac cell repair therapy: a clinical perspective. Mayo Clinic Proceedings. 84: 876-92. PMID 19797777 DOI: 10.1016/S0025-6196(11)60505-3 |
0.365 |
|
| 2009 |
Nelson TJ, Behfar A, Yamada S, Martinez-Fernandez A, Terzic A. Stem cell platforms for regenerative medicine. Clinical and Translational Science. 2: 222-7. PMID 19779576 DOI: 10.1111/J.1752-8062.2009.00096.X |
0.428 |
|
| 2009 |
Schneider JS, Vitale JM, Terzic A, Fraidenraich D. Blastocyst injection of embryonic stem cells: a simple approach to unveil mechanisms of corrections in mouse models of human disease. Stem Cell Reviews. 5: 369-77. PMID 19705303 DOI: 10.1007/S12015-009-9089-6 |
0.416 |
|
| 2009 |
Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y, Terzic A. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circulation Research. 105: 648-56. PMID 19696409 DOI: 10.1161/Circresaha.109.203109 |
0.404 |
|
| 2009 |
Reyes S, Park S, Johnson BD, Terzic A, Olson TM. KATP channel Kir6.2 E23K variant overrepresented in human heart failure is associated with impaired exercise stress response Human Genetics. 126: 779-789. PMID 19685080 DOI: 10.1007/S00439-009-0731-9 |
0.313 |
|
| 2009 |
Arrell DK, Zlatkovic J, Kane GC, Yamada S, Terzic A. ATP-sensitive K+ channel knockout induces cardiac proteome remodeling predictive of heart disease susceptibility Journal of Proteome Research. 8: 4823-4834. PMID 19673485 DOI: 10.1021/Pr900561G |
0.355 |
|
| 2009 |
Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation. 120: 408-16. PMID 19620500 DOI: 10.1161/Circulationaha.109.865154 |
0.464 |
|
| 2009 |
Yamada S, Nelson TJ, Behfar A, Crespo-Diaz RJ, Fraidenraich D, Terzic A. Stem cell transplant into preimplantation embryo yields myocardial infarction-resistant adult phenotype. Stem Cells (Dayton, Ohio). 27: 1697-705. PMID 19544428 DOI: 10.1002/Stem.116 |
0.775 |
|
| 2009 |
Nelson TJ, Terzic A. Induced pluripotent stem cells: reprogrammed without a trace. Regenerative Medicine. 4: 333-335. PMID 19438303 DOI: 10.2217/Rme.09.16 |
0.395 |
|
| 2009 |
Nelson TJ, Chiriac A, Faustino RS, Crespo-Diaz RJ, Behfar A, Terzic A. Lineage specification of Flk-1+ progenitors is associated with divergent Sox7 expression in cardiopoiesis. Differentiation; Research in Biological Diversity. 77: 248-55. PMID 19272523 DOI: 10.1016/J.Diff.2008.10.012 |
0.75 |
|
| 2009 |
Zlatkovic J, Arrell DK, Kane GC, Miki T, Seino S, Terzic A. Proteomic profiling of KATP channel-deficient hypertensive heart maps risk for maladaptive cardiomyopathic outcome Proteomics. 9: 1314-1325. PMID 19253285 DOI: 10.1002/Pmic.200800718 |
0.364 |
|
| 2009 |
Bartunek JJ, Sherman W, Vanderheyden M, Fernandez-Aviles F, Wijns W, Terzic A. Delivery of biologics in cardiovascular regenerative medicine. Clinical Pharmacology & Therapeutics. 85: 548-552. PMID 19212313 DOI: 10.1038/Clpt.2008.295 |
0.417 |
|
| 2009 |
Nelson TJ, Martinez-Fernandez A, Terzic A. KCNJ11 knockout morula re-engineered by stem cell diploid aggregation. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 364: 269-76. PMID 18977736 DOI: 10.1098/Rstb.2008.0179 |
0.346 |
|
| 2009 |
Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A. Cardiac Cell Repair Therapy: A Clinical Perspective Mayo Clinic Proceedings. 84: 876-892. DOI: 10.4065/84.10.876 |
0.465 |
|
| 2008 |
Faustino RS, Terzic A. Interactome of a cardiopoietic precursor. Journal of Cardiovascular Translational Research. 1: 120-6. PMID 20559906 DOI: 10.1007/S12265-008-9019-Z |
0.373 |
|
| 2008 |
Bartunek J, Behfar A, Vanderheyden M, Wijns W, Terzic A. Mesenchymal Stem Cells and Cardiac Repair: Principles and Practice Journal of Cardiovascular Translational Research. 1: 115-119. PMID 20559905 DOI: 10.1007/S12265-008-9021-5 |
0.433 |
|
| 2008 |
Waldman SA, Terzic A. Clinical and Translational Sciences: At the Intersection of Molecular and Individualized Medicine Clinical and Translational Science. 1: 6-8. PMID 20443812 DOI: 10.1111/J.1752-8062.2008.00019.X |
0.315 |
|
| 2008 |
Chung S, Dzeja PP, Faustino RS, Terzic A. Developmental restructuring of the creatine kinase system integrates mitochondrial energetics with stem cell cardiogenesis. Annals of the New York Academy of Sciences. 1147: 254-63. PMID 19076447 DOI: 10.1196/Annals.1427.004 |
0.419 |
|
| 2008 |
Behfar A, Faustino RS, Arrell DK, Dzeja PP, Perez-Terzic C, Terzic A. Guided stem cell cardiopoiesis: discovery and translation. Journal of Molecular and Cellular Cardiology. 45: 523-9. PMID 18835562 DOI: 10.1016/J.Yjmcc.2008.09.122 |
0.457 |
|
| 2008 |
Nelson TJ, Behfar A, Terzic A. Stem cells: biologics for regeneration. Clinical Pharmacology & Therapeutics. 84: 620-623. PMID 18701884 DOI: 10.1038/Clpt.2008.146 |
0.396 |
|
| 2008 |
Yamada S, Nelson TJ, Crespo-Diaz RJ, Perez-Terzic C, Liu XK, Miki T, Seino S, Behfar A, Terzic A. Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Stem Cells (Dayton, Ohio). 26: 2644-53. PMID 18669912 DOI: 10.1634/Stemcells.2008-0187 |
0.788 |
|
| 2008 |
Doyle B, Sorajja P, Hynes B, Kumar AH, Araoz PA, Stalboerger PG, Miller D, Reed C, Schmeckpeper J, Wang S, Liu C, Terzic A, Kruger D, Riederer S, Caplice NM. Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells and Development. 17: 941-51. PMID 18564032 DOI: 10.1089/Scd.2007.0214 |
0.369 |
|
| 2008 |
Reyes S, Terzic A, Mahoney DW, Redfield MM, Rodeheffer RJ, Olson TM. KATP channel polymorphism is associated with left ventricular size in hypertensive individuals: A large-scale community-based study Human Genetics. 123: 665-667. PMID 18504616 DOI: 10.1007/S00439-008-0519-3 |
0.326 |
|
| 2008 |
Nelson TJ, Faustino RS, Chiriac A, Crespo-Diaz R, Behfar A, Terzic A. CXCR4+/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells. Stem Cells (Dayton, Ohio). 26: 1464-73. PMID 18369102 DOI: 10.1634/Stemcells.2007-0808 |
0.774 |
|
| 2008 |
Faustino RS, Behfar A, Perez-Terzic C, Terzic A. Genomic chart guiding embryonic stem cell cardiopoiesis. Genome Biology. 9: R6. PMID 18184438 DOI: 10.1186/Gb-2008-9-1-R6 |
0.393 |
|
| 2008 |
Arrell DK, Niederländer NJ, Faustino RS, Behfar A, Terzic A. Cardioinductive network guiding stem cell differentiation revealed by proteomic cartography of tumor necrosis factor alpha-primed endodermal secretome. Stem Cells (Dayton, Ohio). 26: 387-400. PMID 17991915 DOI: 10.1634/Stemcells.2007-0599 |
0.337 |
|
| 2008 |
Sattiraju S, Reyes S, Kane G, Terzic A. KATP channel pharmacogenomics: From bench to bedside Clinical Pharmacology & Therapeutics. 83: 354-357. PMID 17957187 DOI: 10.1038/Sj.Clpt.6100378 |
0.313 |
|
| 2007 |
Ozcan C, Terzic A, Bienengraeber M. Effective pharmacotherapy against oxidative injury: alternative utility of an ATP-sensitive potassium channel opener. Journal of Cardiovascular Pharmacology. 50: 411-418. PMID 18049309 DOI: 10.1097/Fjc.0B013E31812378Df |
0.311 |
|
| 2007 |
Jahangir A, Sagar S, Terzic A. Aging and cardioprotection. Journal of Applied Physiology (Bethesda, Md. : 1985). 103: 2120-8. PMID 17717116 DOI: 10.1152/Japplphysiol.00647.2007 |
0.33 |
|
| 2007 |
Arrell DK, Niederländer NJ, Perez-Terzic C, Chung S, Behfar A, Terzic A. Pharmacoproteomics: Advancing the efficacy and safety of regenerative therapeutics Clinical Pharmacology and Therapeutics. 82: 316-319. PMID 17671447 DOI: 10.1038/Sj.Clpt.6100310 |
0.32 |
|
| 2007 |
Behfar A, Terzic A. Cardioprotective repair through stem cell-based cardiopoiesis. Journal of Applied Physiology. 103: 1438-1440. PMID 17641218 DOI: 10.1152/Japplphysiol.00713.2007 |
0.462 |
|
| 2007 |
Taneja V, Behrens M, Cooper LT, Yamada S, Kita H, Redfield MM, Terzic A, David C. Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice Journal of Molecular and Cellular Cardiology. 42: 1054-1064. PMID 17499268 DOI: 10.1016/J.Yjmcc.2007.03.898 |
0.302 |
|
| 2007 |
Behfar A, Perez-Terzic C, Faustino RS, Arrell DK, Hodgson DM, Yamada S, Puceat M, Niederländer N, Alekseev AE, Zingman LV, Terzic A. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. The Journal of Experimental Medicine. 204: 405-20. PMID 17283208 DOI: 10.1084/Jem.20061916 |
0.435 |
|
| 2007 |
Chung S, Dzeja PP, Faustino RS, Perez-Terzic C, Behfar A, Terzic A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nature Clinical Practice. Cardiovascular Medicine. 4: S60-7. PMID 17230217 DOI: 10.1038/Ncpcardio0766 |
0.396 |
|
| 2007 |
Gumina RJ, O'Cochlain DF, Kurtz CE, Bast P, Pucar D, Mishra P, Miki T, Seino S, Macura S, Terzic A. KATP channel knockout worsens myocardial calcium stress load in vivo and impairs recovery in stunned heart. American Journal of Physiology. Heart and Circulatory Physiology. 292: H1706-13. PMID 17189350 DOI: 10.1152/Ajpheart.01305.2006 |
0.333 |
|
| 2007 |
Waldman SA, Christensen NB, Moore JE, Terzic A. Clinical pharmacology: the science of therapeutics Clinical Pharmacology & Therapeutics. 81: 3-6. PMID 17185986 DOI: 10.1038/Sj.Clpt.6100032 |
0.317 |
|
| 2007 |
Behfar A, Terzic A. Optimizing adult mesenchymal stem cells for heart repair. Journal of Molecular and Cellular Cardiology. 42: 283-284. PMID 17174974 DOI: 10.1016/J.Yjmcc.2006.11.003 |
0.392 |
|
| 2006 |
Kane GC, Lam CF, O'Cochlain F, Hodgson DM, Reyes S, Liu XK, Miki T, Seino S, Katusic ZS, Terzic A. Gene knockout of the KCNJ8-encoded Kir6.1 K(ATP) channel imparts fatal susceptibility to endotoxemia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2271-80. PMID 17077304 DOI: 10.1096/Fj.06-6349Com |
0.316 |
|
| 2006 |
Yamada S, Kane GC, Behfar A, Liu XK, Dyer RB, Faustino RS, Miki T, Seino S, Terzic A. Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant. The Journal of Physiology. 577: 1053-65. PMID 17038430 DOI: 10.1113/Jphysiol.2006.119511 |
0.363 |
|
| 2006 |
Kane GC, Behfar A, Dyer RB, O'Cochlain DF, Liu XK, Hodgson DM, Reyes S, Miki T, Seino S, Terzic A. KCNJ11 gene knockout of the Kir6.2 KATP channel causes maladaptive remodeling and heart failure in hypertension. Human Molecular Genetics. 15: 2285-97. PMID 16782803 DOI: 10.1093/Hmg/Ddl154 |
0.356 |
|
| 2006 |
Olson TM, Alekseev AE, Liu XK, Park S, Zingman LV, Bienengraeber M, Sattiraju S, Ballew JD, Jahangir A, Terzic A. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation Human Molecular Genetics. 15: 2185-2191. PMID 16772329 DOI: 10.1093/Hmg/Ddl143 |
0.313 |
|
| 2006 |
Behfar A, Terzic A. Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny. Nature Reviews Cardiology. 3. PMID 16501637 DOI: 10.1038/Ncpcardio0429 |
0.465 |
|
| 2006 |
Saks V, Dzeja P, Schlattner U, Vendelin M, Terzic A, Wallimann T. Cardiac system bioenergetics: metabolic basis of the Frank-Starling law. The Journal of Physiology. 571: 253-73. PMID 16410283 DOI: 10.1113/Jphysiol.2005.101444 |
0.31 |
|
| 2006 |
Cha YM, Dzeja PP, Redfield MM, Shen WK, Terzic A. Bioenergetic protection of failing atrial and ventricular myocardium by vasopeptidase inhibitor omapatrilat American Journal of Physiology-Heart and Circulatory Physiology. 290. PMID 16339841 DOI: 10.1152/Ajpheart.00384.2005 |
0.354 |
|
| 2005 |
Behfar A, Hodgson DM, Zingman LV, Perez-Terzic C, Yamada S, Kane GC, Alekseev AE, Pucéat M, Terzic A. Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair. Annals of the New York Academy of Sciences. 1049: 189-98. PMID 15965118 DOI: 10.1196/Annals.1334.018 |
0.463 |
|
| 2005 |
Jahangir A, Terzic A. KATP channel therapeutics at the bedside Journal of Molecular and Cellular Cardiology. 39: 99-112. PMID 15953614 DOI: 10.1016/J.Yjmcc.2005.04.006 |
0.308 |
|
| 2005 |
Kane GC, Liu XK, Yamada S, Olson TM, Terzic A. Cardiac KATP channels in health and disease. Journal of Molecular and Cellular Cardiology. 38: 937-43. PMID 15910878 DOI: 10.1016/J.Yjmcc.2005.02.026 |
0.342 |
|
| 2005 |
KANE G, BEHFAR A, YAMADA S, PEREZTERZIC C, REYES S, DZEJA P, MIKI T, SEINO S, TERZIC A. Deficit in the sulfonylurea receptor KATP channel complex compromises the metabolic benefit of exercise training resulting in cardiac deficits Clinical Pharmacology & Therapeutics. 77: P54-P54. DOI: 10.1016/J.Clpt.2004.12.097 |
0.31 |
|
| 2005 |
Behfar A, Perez‐Terzic C, Hodgson DM, Alekseev AE, Kane GC, Puceat M, Terzic A. Guided cardiogenesis for safe stem cell‐based therapy Clinical Pharmacology & Therapeutics. 77. DOI: 10.1016/J.Clpt.2004.11.015 |
0.457 |
|
| 2004 |
Liu XK, Yamada S, Kane GC, Alekseev AE, Hodgson DM, O'Cochlain F, Jahangir A, Miki T, Seino S, Terzic A. Genetic disruption of Kir6.2, the pore-forming subunit of ATP-sensitive K+ channel, predisposes to catecholamine-induced ventricular dysrhythmia. Diabetes. 53: S165-8. PMID 15561906 DOI: 10.2337/Diabetes.53.Suppl_3.S165 |
0.331 |
|
| 2004 |
Hodgson DM, Behfar A, Zingman LV, Kane GC, Perez-Terzic C, Alekseev AE, Pucéat M, Terzic A. Stable benefit of embryonic stem cell therapy in myocardial infarction American Journal of Physiology-Heart and Circulatory Physiology. 287: 471-479. PMID 15277190 DOI: 10.1152/Ajpheart.01247.2003 |
0.419 |
|
| 2004 |
Holmuhamedov EL, Jahangir A, Oberlin A, Komarov A, Colombini M, Terzic A. Potassium channel openers are uncoupling protonophores: implication in cardioprotection. Febs Letters. 568: 167-70. PMID 15196941 DOI: 10.1016/J.Febslet.2004.05.031 |
0.304 |
|
| 2004 |
Bienengraeber M, Olson TM, Selivanov VA, Kathmann EC, O'Cochlain F, Gao F, Karger AB, Ballew JD, Hodgson DM, Zingman LV, Pang YP, Alekseev AE, Terzic A. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nature Genetics. 36: 382-7. PMID 15034580 DOI: 10.1038/Ng1329 |
0.332 |
|
| 2004 |
Méry A, Papadimou E, Zeineddine D, Ménard C, Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Perez-Terzic C, Terzic A, Pucéat M. Commitment of embryonic stem cells toward a cardiac lineage: molecular mechanisms and evidence for a promising therapeutic approach for heart failure. Journal of Muscle Research and Cell Motility. 24: 269-74. PMID 14620740 |
0.33 |
|
| 2003 |
Ozcan C, Bienengraeber M, Hodgson DM, Mann DL, Terzic A. Mitochondrial tolerance to stress impaired in failing heart Journal of Molecular and Cellular Cardiology. 35: 1161-1166. PMID 12967639 DOI: 10.1016/S0022-2828(03)00204-9 |
0.338 |
|
| 2003 |
Bienengraeber M, Ozcan C, Terzic A. Stable transfection of UCP1 confers resistance to hypoxia/reoxygenation in a heart-derived cell line. Journal of Molecular and Cellular Cardiology. 35: 861-865. PMID 12818577 DOI: 10.1016/S0022-2828(03)00147-0 |
0.334 |
|
| 2003 |
Bienengraeber M, Hodgson DM, Zingman LV, Alekseev AE, Terzic A. Identity and function of cardiac KATP channels Journal of Molecular and Cellular Cardiology. 35: 433-435. PMID 12738225 DOI: 10.1016/S0022-2828(03)00074-9 |
0.303 |
|
| 2003 |
Hodgson DM, Zingman LV, Kane GC, Perez‐Terzic C, Bienengraeber M, Ozcan C, Gumina RJ, Pucar D, O'Coclain F, Mann DL, Alekseev AE, Terzic A. Cellular remodeling in heart failure disrupts KATP channel‐dependent stress tolerance The Embo Journal. 22: 1732-1742. PMID 12682006 DOI: 10.1093/Emboj/Cdg192 |
0.357 |
|
| 2003 |
Perez-Terzic C, Behfar A, Méry A, van Deursen JM, Terzic A, Pucéat M. Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes. Circulation Research. 92: 444-52. PMID 12600892 DOI: 10.1161/01.Res.0000059415.25070.54 |
0.416 |
|
| 2003 |
Gumina RJ, Pucar D, Bast P, Hodgson DM, Kurtz CE, Dzeja PP, Miki T, Seino S, Terzic A. Knockout of Kir6.2 negates ischemic preconditioning-induced protection of myocardial energetics. American Journal of Physiology-Heart and Circulatory Physiology. 284. PMID 12598229 DOI: 10.1152/Ajpheart.00057.2003 |
0.305 |
|
| 2003 |
Méry A, Papadimou E, Zeineddine D, Ménard C, Behfar A, Zingman LV, Hodgson DM, Rauzier J, Kane GC, Perez-Terzic C, Terzic A, Pucéat M. Commitment of embryonic stem cells toward a cardiac lineage: molecular mechanisms and evidence for a promising therapeutic approach for heart failure. Journal of Muscle Research and Cell Motility. 24: 269-274. DOI: 10.1023/A:1025421622414 |
0.44 |
|
| 2002 |
Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Terzic A, Pucéat M. Stem cell differentiation requires a paracrine pathway in the heart The Faseb Journal. 16: 1558-1566. PMID 12374778 DOI: 10.1096/Fj.02-0072Com |
0.39 |
|
| 2002 |
Zingman LV, Hodgson DM, Bast PH, Kane GC, Perez-Terzic C, Gumina RJ, Pucar D, Bienengraeber M, Dzeja PP, Miki T, Seino S, Alekseev AE, Terzic A. Kir6.2 is required for adaptation to stress. Proceedings of the National Academy of Sciences of the United States of America. 99: 13278-83. PMID 12271142 DOI: 10.1073/Pnas.212315199 |
0.307 |
|
| 2002 |
Pucar D, Bast P, Gumina RJ, Lim L, Drahl C, Juranic N, Macura S, Janssen E, Wieringa B, Terzic A, Dzeja PP. Adenylate kinase AK1 knockout heart: energetics and functional performance under ischemia-reperfusion. American Journal of Physiology. Heart and Circulatory Physiology. 283: H776-82. PMID 12124227 DOI: 10.1152/Ajpheart.00116.2002 |
0.332 |
|
| 2002 |
Gumina RJ, Jahangir A, Gross GJ, Terzic A. Cardioprotection: emerging pharmacotherapy. Expert Opinion On Pharmacotherapy. 2: 739-52. PMID 11336619 DOI: 10.1517/14656566.2.5.739 |
0.303 |
|
| 2001 |
Melamed‐Frank M, Terzic A, Carrasco AJ, Nevo E, Avivi A, Levy AP. Reciprocal regulation of expression of pore-forming KATP channel genes by hypoxia. Molecular and Cellular Biochemistry. 225: 145-150. PMID 11716356 DOI: 10.1023/A:1012286624993 |
0.312 |
|
| 2001 |
Pucar D, Dzeja PP, Bast P, Juranic N, Macura S, Terzic A. Cellular energetics in the preconditioned state: protective role for phosphotransfer reactions captured by 18O-assisted 31P NMR. The Journal of Biological Chemistry. 276: 44812-9. PMID 11583991 DOI: 10.1074/Jbc.M104425200 |
0.313 |
|
| 2001 |
Dzeja PP, Holmuhamedov EL, Ozcan C, Pucar D, Jahangir A, Terzic A. Mitochondria Circulation Research. 89: 744-746. DOI: 10.1161/Res.89.9.744 |
0.308 |
|
| 2000 |
Jovanović S, Jovanović A, Shen WK, Terzic A. Low concentrations of 17beta-estradiol protect single cardiac cells against metabolic stress-induced Ca2+ loading. Journal of the American College of Cardiology. 36: 948-52. PMID 10987624 DOI: 10.1016/S0735-1097(00)00798-1 |
0.316 |
|
| 2000 |
Dzeja PP, Redfield MM, Burnett JC, Terzic A. Failing energetics in failing hearts Current Cardiology Reports. 2: 212-217. PMID 10980895 DOI: 10.1007/S11886-000-0071-9 |
0.35 |
|
| 2000 |
Lisy O, Redfield MM, Jovanovic S, Jougasaki M, Jovanovic A, Leskinen H, Terzic A, Burnett JC. Mechanical unloading versus neurohumoral stimulation on myocardial structure and endocrine function In vivo. Circulation. 102: 338-43. PMID 10899099 DOI: 10.1161/01.Cir.102.3.338 |
0.321 |
|
| 2000 |
Chen HH, Oh KY, Terzic A, Burnett JCJ. The modulating actions of sulfonylurea on atrial natriuretic peptide release in experimental acute heart failure. European Journal of Heart Failure. 2: 33-40. PMID 10742701 DOI: 10.1016/S1388-9842(99)00074-4 |
0.335 |
|
| 2000 |
Jovanovic S, Grantham AJ, Tarara JE, Burnett JC, Jovanovic A, Terzic A. Increased number of cardiomyocytes in cross-sections from tachycardia-induced cardiomyopathic hearts. International Journal of Molecular Medicine. 3: 153-5. PMID 9917522 DOI: 10.3892/Ijmm.3.2.153 |
0.375 |
|
| 1999 |
Dzeja PP, Pucar D, Redfield MM, Burnett JC, Terzic A. Reduced activity of enzymes coupling ATP-generating with ATP-consuming processes in the failing myocardium Molecular and Cellular Biochemistry. 201: 33-40. PMID 10630620 DOI: 10.1023/A:1007016703229 |
0.301 |
|
| 1999 |
Abraham MR, Jahangir A, Alekseev AE, Terzic A. Channelopathies of inwardly rectifying potassium channels. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 13: 1901-10. PMID 10544173 DOI: 10.1096/Fasebj.13.14.1901 |
0.303 |
|
| 1999 |
D'Hahan N, Moreau C, Prost AL, Jacquet H, Alekseev AE, Terzic A, Vivaudou M. Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP Proceedings of the National Academy of Sciences of the United States of America. 96: 12162-12167. PMID 10518593 DOI: 10.1073/Pnas.96.21.12162 |
0.323 |
|
| 1999 |
Perez-Terzic C, Gacy AM, Bortolon R, Dzeja PP, Puceat M, Jaconi M, Prendergast FG, Terzic A. Structural plasticity of the cardiac nuclear pore complex in response to regulators of nuclear import. Circulation Research. 84: 1292-301. PMID 10364567 DOI: 10.1161/01.Res.84.11.1292 |
0.317 |
|
| 1999 |
Dzeja PP, Vitkevicius KT, Redfield MM, Burnett JC, Terzic A. Adenylate kinase-catalyzed phosphotransfer in the myocardium: Increased contribution in heart failure Circulation Research. 84: 1137-1143. PMID 10347088 DOI: 10.1161/01.Res.84.10.1137 |
0.314 |
|
| 1999 |
Zhang W, Mannan I, Schulz S, Parkinson SJ, Alekseev AE, Gomez LA, Terzic A, Waldman SA. Interruption of transmembrane signaling as a novel antisecretory strategy to treat enterotoxigenic diarrhea. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 13: 913-22. PMID 10224234 DOI: 10.1096/Fasebj.13.8.913 |
0.325 |
|
| 1999 |
Jovanović S, Jovanović A, Shen WK, Terzic A. Protective action of 17beta-estradiol in cardiac cells: implications for hyperkalemic cardioplegia. The Annals of Thoracic Surgery. 66: 1658-61. PMID 9875767 DOI: 10.1016/S0003-4975(98)00893-5 |
0.317 |
|
| 1998 |
Jovanović A, Jovanović S, Lorenz E, Terzic A. Recombinant cardiac ATP-sensitive K+ channel subunits confer resistance to chemical hypoxia-reoxygenation injury. Circulation. 98: 1548-55. PMID 9769309 DOI: 10.1161/01.Cir.98.15.1548 |
0.301 |
|
| 1998 |
Brady PA, Terzic A. The sulfonylurea controversy: more questions from the heart. Journal of the American College of Cardiology. 31: 950-6. PMID 9561992 DOI: 10.1016/S0735-1097(98)00038-2 |
0.327 |
|
| 1998 |
Jovanovic A, Jovanovic S, Mays DC, Lipsky JJ, Terzic A. Diadenosine 5',5"-P1,P5-pentaphosphate harbors the properties of a signaling molecule in the heart. Febs Letters. 423: 314-318. PMID 9515730 DOI: 10.1016/S0014-5793(98)00114-8 |
0.351 |
|
| 1998 |
Jovanović A, Lopez JR, Alekseev AE, Shen WK, Terzic A. Adenosine prevents K+-induced Ca2+ loading: insight into cardioprotection during cardioplegia. The Annals of Thoracic Surgery. 65: 586-91. PMID 9485282 DOI: 10.1016/S0003-4975(97)01240-X |
0.323 |
|
| 1998 |
Brady PA, Al-Suwaidi J, Kopecky SL, Terzic A. Sulfonylureas and Mortality in Diabetic Patients After Myocardial Infarction Circulation. 97. DOI: 10.1161/Circ.97.7.709/A |
0.301 |
|
| 1997 |
Gomez LA, Alekseev AE, Aleksandrova LA, Brady PA, Terzic A. Use of the MTT assay in adult ventricular cardiomyocytes to assess viability: effects of adenosine and potassium on cellular survival. Journal of Molecular and Cellular Cardiology. 29: 1255-66. PMID 9160877 DOI: 10.1006/Jmcc.1996.0363 |
0.327 |
|
| 1997 |
Alekseev AE, Gomez LA, Aleksandrova LA, Brady PA, Terzic A. Opening of cardiac sarcolemmal KATP channels by dinitrophenol separate from metabolic inhibition. The Journal of Membrane Biology. 157: 203-14. PMID 9151661 DOI: 10.1007/S002329900229 |
0.304 |
|
| 1997 |
Parkinson SJ, Alekseev AE, Gomez LA, Wagner F, Terzic A, Waldman SA. Interruption of Escherichia coli heat-stable enterotoxin-induced guanylyl cyclase signaling and associated chloride current in human intestinal cells by 2-chloroadenosine. The Journal of Biological Chemistry. 272: 754-8. PMID 8995360 DOI: 10.1074/Jbc.272.2.754 |
0.318 |
|
| 1997 |
Jovanović A, Alekseev AE, López JR, Shen WK, Terzic A. Adenosine prevents hyperkalemia-induced calcium loading in cardiac cells: relevance for cardioplegia. The Annals of Thoracic Surgery. 63: 153-61. PMID 8993258 DOI: 10.1016/S0003-4975(96)00769-2 |
0.332 |
|
| 1996 |
López JR, Jahangir R, Jahangir A, Shen WK, Terzic A. Potassium channel opening drugs prevent cardioplegic solution-induced intracellular Ca2+ loading in cardiac cells Clinical Pharmacology & Therapeutics. 59: 175-175. DOI: 10.1038/Sj.Clpt.1996.198 |
0.31 |
|
| 1995 |
Terzic A, Jahangir A, Kurachi Y. Cardiac ATP-sensitive K+ channels: regulation by intracellular nucleotides and K+ channel-opening drugs American Journal of Physiology-Cell Physiology. 269. PMID 7573382 DOI: 10.1152/Ajpcell.1995.269.3.C525 |
0.318 |
|
| 1992 |
Terzic A, Pucéat M, Clément-Chomienne O, Vassort G. Phenylephrine and ATP enhance an amiloride insensitive bicarbonate-dependent alkalinizing mechanism in rat single cardiomyocytes Naunyn-Schmiedebergs Archives of Pharmacology. 346: 597-600. PMID 1335129 DOI: 10.1007/Bf00169019 |
0.305 |
|
| 1991 |
Terzic A, Pucéat M, Clément O, Vassort G. α1-Adrenoceptors regulate pHi in single isolated cardiac cells Journal of Molecular and Cellular Cardiology. 23. DOI: 10.1016/0022-2828(91)90398-6 |
0.317 |
|
| Show low-probability matches. |